Engelsk titel: Changing clinicians' prescription patterns
Läs online
Författare:
Reuther LÖ
;
Christensen HR
;
Mikkelsen C
Email: lenereuther@hotmail.com
Språk: Dan
Antal referenser: 5
Dokumenttyp:
Artikel
UI-nummer: 09091448
Sammanfattning
In 2005 the Central Drug Committee in co-operation with the hospitals in the county of Copenhagen (H:S) focused on the increasing use of and expenditure derived from three tumour necrosis factor alpha (TNF-alpha) inhibitors. While the three inhibitors are estimated to be equivalent regarding efficacy and safety, eternacept and adalimumab are twice as expensive as infliximab. With a little effort, the Central Drug Committee succeeded in changing clinicians' prescription pattern in a cost-effective manner.